Anticoagulants in tuberculostatic therapy
Bethge
Deutsche Medizinische Wochenschrift 102(15): 590
1977
ISSN/ISBN: 0012-0472 PMID: 849720 Document Number: 122379
Document emailed within 1 workday
Related Documents
Irriguible, M.D.; Miquel, C.; Rubies-Prat, J. 1978: Erythroblastopenia associated with tuberculostatic therapy Sangre 23(1): 80-84Schulz, V.; Theisen, H. 1971: Allergic reaction after therapy with tuberculostatic agent Myambutol Die Medizinische Welt 3: 114-115
Weigel, B. 1976: Changes of the tuberculosis of the central nervous system since the introduction of prophylactic BCG vaccination and tuberculostatic therapy Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 120(1): 21-33
Vergoz, D. 1982: Improper therapy in phlebology. Anticoagulants Phlebologie 35(4): 805-817
Hitzeman, N.; Applebaum, S. 2008: Oral anticoagulants vs. antiplatelet therapy American Family Physician 77(9): 1250-1252
Loeliger, E.A. 1973: Therapy using oral anticoagulants. Experience report from Holland. 1 Therapie der Gegenwart 112(7): 1159 Passim
Handler, J.A.; Feied, C.F. 1995: Acute pulmonary embolism. Aggressive therapy with anticoagulants and thrombolytics Postgraduate Medicine 97(1): 61
Latallo, Z.S.; Malanowicz, W. 1970: Anticoagulant therapy in cardiovascular diseases. I. Thrombus formation and anticoagulants Kardiologia Polska 13(4): 351-358
Kalff, R.; Kocks, W.; Roosen, K.; Grote, W.; Lang, W. 1987: Paresis of the femoral nerve following spontaneous retroperitoneal hemorrhage in therapy using anticoagulants Medizinische Klinik 82(2): 72-76
Gianetti, J.; Gensini, G.; De Caterina, R. 1998: A cost-effectiveness analysis of aspirin versus oral anticoagulants after acute myocardial infarction in Italy -- equivalence of costs as a possible case for oral anticoagulants Thrombosis and Haemostasis 80(6): 887-893
Dick, B.; Stoffelns, B.; Pfeiffer, N. 1997: Cataract operation during therapy with anticoagulants. Principles, perioperative procedure, complications and recommendations Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 94(5): 372-384
Exner, T.; Triplett, D.A.; Taberner, D.; Machin, S.J. 1991: Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants Thrombosis and Haemostasis 65(3): 320-322
Ferreira, R. 1992: First Course of cardiovascular clinical pharmacology. II. Adjuvant therapy to thrombolysis. Anticoagulants and platelet aggregation inhibitors Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(3): 261-264
Zubenko, V.G.; Ladna, L.I.; Turkevich, M.M.; Tatchin-Kapustiak, S.M. 1974: Synthesis and tuberculostatic activity of azolidines Farmatsevtychnyi Zhurnal 29(3): 78-82
Oshima, S. 1974: Tuberculostatic factor in human urine Kekkaku: 49(9): 263-265
Ion, N.; Jemma, I.; Sfetcu, V. 1981: Presence of antibodies against rifampicin in patients under tuberculostatic treatment Revista de Igiena Bacteriologie Virusologie Parazitologie Epidemiologie Pneumoftiziologie. Pneumoftiziologia 30(1): 39-42
Dănilă, G.; Radu, C. 1978: Derivatives of 2-thion-3-isonicotinoylamino-thiazolid-4-one with tuberculostatic activity Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 82(1): 127-130
Ruckdeschel, G.; Stransky, D.; Schönenberger, H. 1976: The relationship between structure and tuberculostatic effect in the benzylamine group Die Pharmazie 31(6): 374-381
Czarnocka-Janowicz, A.; Janowiec, M. 1983: Synthesis and tuberculostatic action of various 1-H-imidazo(4,5-c)pyridine derivatives Acta Poloniae Pharmaceutica 40(1): 7-14
Saczewski, F. 1993: Synthesis, transformations and tuberculostatic activity of 1-(N-aroylthiocarbamoyl)imidiazolidine-2-thiones Acta Poloniae Pharmaceutica 50(4-5): 341-344